Shamburg News · 8-K filed Oct 6, 2026, 4:57 PM EDT

Quince Therapeutics Stockholders Approve 2026 Equity Plan, ESPP and Authorized Share Increase

IRLA · Quince Therapeutics, Inc.

  • Shareholder vote
  • Other
  • Materiality: medium

At a special meeting held October 6, 2026, Quince Therapeutics, Inc. stockholders approved the 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan, with an initial share reserve of 821,872 shares under the equity plan and 142,045 shares under the ESPP. Stockholders also approved an amendment increasing authorized common stock from 250,000,000 to 275,000,000 shares, effective October 6, 2026. Stockholders approved proposals to issue common stock upon conversion of Series C Preferred Stock and warrants, including a proposal that may result in a change of control under Nasdaq Listing Rule 5635(b).

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 5.02, 5.03, 5.07, 9.01, accession 0001193125-26-415730.

Written from the filing by Shamburg Markets. Figures are as reported by the company.